A Phase 2b Multicenter Study to Evaluate Basmisanil as an Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia

Journal of Clinical Psychiatry · Published 2026-04-15 · DOI 10.4088/jcp.25m16022

Authors being retrieved — see the publisher record. https://doi.org/10.4088/jcp.25m16022

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• The Efficacy of Olanzapine/Samidorphan on Negative Symptoms · Journal of Clinical Psychiatry · 2026 · Same journal
• Gestational Exposure to Sterol Biosynthesis Disrupting Drugs and Risk of Autism Spectrum Disorder in Offspring · Journal of Clinical Psychiatry · 2026 · Same journal
• Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History · Journal of Clinical Psychiatry · 2026 · Same journal
• Proton Pump Inhibitors and the Risk of Dementia · Journal of Clinical Psychiatry · 2026 · Same journal
• Catatonia as a Case Study in Psychiatric Decision-Making · Journal of Clinical Psychiatry · 2026 · Same journal
• Mind and Metabolism in Crisis · Journal of Clinical Psychiatry · 2026 · Same journal
• A Growing Epidemic of Loneliness Among US Military Veterans · Journal of Clinical Psychiatry · 2026 · Same journal
• The Challenges of PTSD Prevention · Journal of Clinical Psychiatry · 2026 · Same journal
• Correlates and Predictors of Criminal Legal Involvement in People With First-Episode Psychosis · Journal of Clinical Psychiatry · 2026 · Same journal
• Psychiatrists and Medical Aid in Dying · Journal of Clinical Psychiatry · 2026 · Same journal